Video
Catch up on the exciting Aesthetic Society accomplishments and advances that took place in 2023.
The Aesthetic Society Year in Review 2023/2024
Related Articles
This is my last newsletter as President of The Aesthetic Foundation, and it has been a busy and productive year. Our core mission is to support research that is relevant to practicing plastic surgeons and improve the safety and effectiveness of the procedures that we offer to our patients.
It is just about two months from The Aesthetic MEET, and we have no lack of education, networking, and fun for you to take part in while you are in Boston. There are many opportunities to engage with and support The Aesthetic Foundation during The MEET, and I look forward to connecting and sharing all that has been accomplished with you.
Biostimulators and energy-based devices are increasingly used in combination to address visible signs of aging.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”
We did it!! 🎉
The Aesthetic Surgery Journal now holds the highest Impact Factor in plastic surgery 3.9! This catapults ASJ into first place in our specialty (both plastic and aesthetic surgery) for the first time!